Latest Taro Pharmaceutical Industries News & Updates

See the latest news and media coverage for Taro. We track all announcements, press releases, and industry mentions in real time, all in one place.

Taro Pharmaceutical Industries (Taro)

Generic pharmaceutical and consumer healthcare company

taro.com

Headquarters: United States
Company type: Public company
Number of employees: 1,200–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Taro Pharmaceutical Industries (Taro)

In short: Taro Pharmaceutical Industries agreed to a merger with Sun Pharma, appointed an interim CEO, and faced multiple shareholder lawsuits.

Company announcements

23 May 2024 Taro

Taro shareholders approved merger with Sun Pharma

The merger was approved at meetings on May 22, 2024, and is expected to close in about 35 days, pending conditions.

17 January 2024 Taro

Taro announces merger agreement with Sun Pharma

Sun Pharma will acquire all outstanding Taro shares for US$43.00 per share in cash.

14 September 2013 Taro

Taro Pharma announces USFDA approval for generic Prevacid

The generic lansoprazole delayed-release capsules are approved by the FDA.

4 June 2013 Taro

Taro announces USFDA approval for generic Depo-Testosterone Injection

This approval allows Taro to market a generic alternative to Depo-Testosterone Injection.

Media coverage

August 13 Pharmaceutical Executive

Taro Appoints Interim CEO | PharmExec

Taro Pharmaceutical Industries (Hawthorne, NY) announced that its Board of Directors has appointed Mr. Abhay Gandhi to the position of Interim Chief Executive Officer, effective...

July 28 Stockhouse

Taro Pharmaceutical Industries Ltd Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation

LOS ANGELES, CA / ACCESSWIRE / September 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a...

July 21 Ad hoc news

Taro stock reflects recent acquisition as investors weigh Sun Pharma deal and earnings trends

Nevertheless, the underlying ... progresses. For longer term oriented investors, these metrics also provide a sense of what the combined group will inherit once Taro...

July 6 Stockhouse

FINAL TARO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Taro Pharmaceutical Industries Ltd. Investors to Join the Class Action Lawsuit!

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased...

Never miss news about Taro

Track Taro and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Taro competitors & trending companies

Browse news for competitors to Taro and other trending companies.